Department of Epidemiology, School of Public Health, West Virginia University, Morgantown, WV, USA.
Department of Epidemiology, School of Rural and Community Health, University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Diabet Med. 2018 Jun;35(6):729-736. doi: 10.1111/dme.13617. Epub 2018 Mar 30.
To estimate the overall and cause-specific mortality in a population of African-Americans and white Americans with a low socio-economic status who had young-onset insulin-treated diabetes and had survived beyond the age of 40 years, and to examine whether any excess risk varied according to age at diabetes onset.
Using the Southern Community Cohort Study, we conducted a mortality follow-up of a cohort of mostly low-income participants aged 40-79 years (mean 50 years) at cohort entry with insulin-treated diabetes diagnosed before age 30 years (n=475) and without diabetes (n=62 266). Childhood onset was defined as diabetes diagnosed before age 20 years (n=162), while young-adulthood onset was defined as diabetes diagnosed between ages 20 and 29 years (n=313). Cause-specific mortality was based on both underlying and contributing causes of death, obtained from death certificates. Multivariable Cox analysis was performed.
During follow-up (mean 9.5 years), 38.7% of those with and 12.9% of those without diabetes died. Compared with those without diabetes, increases in mortality rate were generally similar among those with childhood- and young-adulthood-onset diabetes for deaths from: all causes (childhood: hazard ratio 4.3, CI 3.3-5.5; young adulthood: hazard ratio 4.9, CI 4.0-5.8); ischaemic heart disease (childhood: hazard ratio 5.7, CI 3.5-9.4; young adulthood: hazard ratio 7.9, CI 5.6-11.0); heart failure (childhood: hazard ratio 7.3, CI 4.2-12.7; young adulthood: hazard ratio 5.4, CI 3.3-8.9); sepsis (childhood: hazard ratio 10.3, CI 6.1-17.3; young adulthood: hazard ratio 8.8, CI 5.7-13.5); renal failure (childhood: hazard ratio 15.1, CI 8.6-26.5; young adulthood: hazard ratio 18.2, CI 12.3-27.1); respiratory disorders (childhood: hazard ratio 3.9, CI 2.3-6.7; young adulthood: hazard ratio 5.3, CI 3.7-7.7); suicide/homicide/accidents (childhood: hazard ratio 2.3, CI 0.72-7.0; young adulthood: hazard ratio 5.8, CI 3.4-10.2); and cancer (childhood: hazard ratio 2.1, CI 0.98-4.4; young adulthood: hazard ratio 1.2, CI 0.55-2.5).
We observed high excess long-term mortality for all-cause, renal failure, ischemic heart disease and heart failure mortality in African-American and white American people with early-onset insulin-treated diabetes.
评估具有低社会经济地位的非裔美国人和美国白人群体中,年轻时接受胰岛素治疗的糖尿病患者的总体和特定原因死亡率,这些患者的年龄超过 40 岁,并研究糖尿病发病年龄是否会影响任何超额风险。
使用南方社区队列研究,我们对一个主要是低收入参与者的队列进行了死亡率随访,这些参与者在队列入组时年龄为 40-79 岁(平均年龄 50 岁),并且在 30 岁之前(n=475)接受胰岛素治疗诊断出患有糖尿病,没有糖尿病(n=62266)。儿童期发病定义为 20 岁之前诊断出的糖尿病(n=162),而青年发病定义为 20-29 岁之间诊断出的糖尿病(n=313)。根据死亡证明,我们基于根本原因和促成原因的死亡来确定特定原因的死亡率。使用多变量 Cox 分析进行分析。
在随访期间(平均 9.5 年),有糖尿病的患者中有 38.7%死亡,而没有糖尿病的患者中有 12.9%死亡。与没有糖尿病的患者相比,儿童期和青年期发病的糖尿病患者的全因死亡率增加大致相似:所有原因(儿童期:风险比 4.3,95%CI 3.3-5.5;青年期:风险比 4.9,95%CI 4.0-5.8);缺血性心脏病(儿童期:风险比 5.7,95%CI 3.5-9.4;青年期:风险比 7.9,95%CI 5.6-11.0);心力衰竭(儿童期:风险比 7.3,95%CI 4.2-12.7;青年期:风险比 5.4,95%CI 3.3-8.9);败血症(儿童期:风险比 10.3,95%CI 6.1-17.3;青年期:风险比 8.8,95%CI 5.7-13.5);肾衰竭(儿童期:风险比 15.1,95%CI 8.6-26.5;青年期:风险比 18.2,95%CI 12.3-27.1);呼吸障碍(儿童期:风险比 3.9,95%CI 2.3-6.7;青年期:风险比 5.3,95%CI 3.7-7.7);自杀/杀人/意外(儿童期:风险比 2.3,95%CI 0.72-7.0;青年期:风险比 5.8,95%CI 3.4-10.2);癌症(儿童期:风险比 2.1,95%CI 0.98-4.4;青年期:风险比 1.2,95%CI 0.55-2.5)。
我们观察到非裔美国人和美国白人群体中,年轻时接受胰岛素治疗的糖尿病患者存在全因、肾衰竭、缺血性心脏病和心力衰竭死亡率的长期高超额风险。